Glenmede Trust Co. NA Sells 5,313 Shares of Itron, Inc. $ITRI

Glenmede Trust Co. NA reduced its stake in Itron, Inc. (NASDAQ:ITRI) by 15.0% during the first quarter, according to its most recent filing with the SEC. The fund owned 30,017 shares of the scientific and technical instruments company’s stock after selling 5,313 shares during the quarter. Glenmede Trust Co. NA owned 0.07% of Itron worth $2,690,000 at the end of the most recent quarter.

A number of other large investors have also added to or reduced their stakes in the stock. Capital World Investors bought a new position in shares of Itron during the 4th quarter valued at approximately $10,460,000. Peregrine Capital Management LLC increased its stake in shares of Itron by 19.3% during the 4th quarter. Peregrine Capital Management LLC now owns 103,474 shares of the scientific and technical instruments company’s stock worth $9,609,000 after purchasing an additional 16,742 shares during the last quarter. DNB Asset Management AS bought a new stake in shares of Itron in the 4th quarter worth approximately $12,191,000. WINTON GROUP Ltd bought a new stake in shares of Itron in the 4th quarter worth approximately $5,795,000. Finally, Fieldview Capital Management LLC lifted its stake in Itron by 54.1% in the fourth quarter. Fieldview Capital Management LLC now owns 40,095 shares of the scientific and technical instruments company’s stock valued at $3,723,000 after purchasing an additional 14,079 shares during the last quarter. Hedge funds and other institutional investors own 96.19% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages have weighed in on ITRI. Stephens reissued an “overweight” rating and set a $130.00 price objective on shares of Itron in a report on Wednesday, May 20th. TD Cowen lowered their target price on Itron from $145.00 to $130.00 and set a “buy” rating on the stock in a research note on Wednesday, April 29th. Roth Capital reiterated a “buy” rating and set a $136.00 price target on shares of Itron in a research note on Wednesday, April 29th. Raymond James Financial initiated coverage on Itron in a research note on Tuesday, April 21st. They set an “underperform” rating for the company. Finally, Oppenheimer boosted their price objective on Itron from $133.00 to $135.00 and gave the company an “outperform” rating in a research note on Thursday, April 16th. Eight research analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, Itron currently has an average rating of “Moderate Buy” and an average price target of $131.33.

Insider Activity

In other Itron news, SVP John F. Marcolini sold 322 shares of the firm’s stock in a transaction dated Tuesday, May 26th. The stock was sold at an average price of $84.37, for a total value of $27,167.14. Following the completion of the transaction, the senior vice president owned 24,689 shares in the company, valued at $2,083,010.93. This trade represents a 1.29% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Joan S. Hooper sold 442 shares of Itron stock in a transaction dated Tuesday, May 26th. The shares were sold at an average price of $84.37, for a total value of $37,291.54. Following the transaction, the chief financial officer directly owned 117,478 shares of the company’s stock, valued at $9,911,618.86. The trade was a 0.37% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last three months, insiders sold 3,946 shares of company stock worth $324,420. 1.77% of the stock is owned by corporate insiders.

Itron Stock Up 5.3%

Itron stock opened at $106.29 on Wednesday. Itron, Inc. has a 1-year low of $77.77 and a 1-year high of $142.00. The firm has a market capitalization of $4.65 billion, a price-to-earnings ratio of 17.74, a P/E/G ratio of 0.83 and a beta of 1.30. The company has a current ratio of 2.75, a quick ratio of 2.29 and a debt-to-equity ratio of 0.96. The firm has a 50 day simple moving average of $85.50 and a 200 day simple moving average of $89.90.

Itron (NASDAQ:ITRI) last issued its earnings results on Tuesday, July 28th. The scientific and technical instruments company reported $1.59 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.29 by $0.30. The business had revenue of $562.90 million for the quarter, compared to analysts’ expectations of $566.34 million. Itron had a net margin of 11.90% and a return on equity of 19.26%. The business’s revenue for the quarter was down 7.2% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.62 EPS. Itron has set its Q3 2026 guidance at 1.500-1.600 EPS and its FY 2026 guidance at 6.300-6.500 EPS. On average, analysts predict that Itron, Inc. will post 6.43 earnings per share for the current year.

Itron Profile

Itron, Inc (NASDAQ: ITRI) is a global technology company that develops innovative solutions to measure, manage and analyze the use of energy and water. Its comprehensive portfolio includes smart meters, data collection devices, communication networks and advanced software applications designed to optimize utility operations and foster sustainable resource management. The company’s offerings enable utilities and cities to accurately monitor consumption patterns, streamline billing processes and improve grid reliability.

Itron’s product lineup spans a range of hardware and software solutions, from residential and commercial smart meters to meter data management systems (MDMS), networked communication platforms and analytics tools.